Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016;5(2):55-8.
doi: 10.2217/cns-2016-0006. Epub 2016 Mar 21.

Personalized medicine in neuro-oncology

Victor A Levin  1   2   3
Affiliations

Personalized medicine in neuro-oncology

Victor A Levin. CNS Oncol. 2016.
No abstract available

Keywords: biomarkers; chemotherapy; genetics; glioblastoma; glioma.

PubMed Disclaimer

Conflict of interest statement

Financial & competing interests disclosure

The author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistance was utilized in the production of this manuscript.

References

    1. Workman P, Clarke PA, Al-Lazikani B. Personalized medicine: patient-predictive panel power. Cancer Cell. 2012;21(4):455–458. - PubMed
    1. Yost SE, Pastorino S, Rozenzhak S, et al. High-resolution mutational profiling suggests the genetic validity of glioblastoma patient-derived pre-clinical models. PLoS ONE. 2013;8(2):e56185. - PMC - PubMed
    1. Colman H, Aldape K. Molecular predictors in glioblastoma: toward personalized therapy. Arch. Neurol. 2008;65(7):877–883. - PubMed
    1. Madhavan S, Zenklusen JC, Kotliarov Y, Sahni H, Fine HA, Buetow K. Rembrandt: helping personalized medicine become a reality through integrative translational research. Mol. Cancer Res. 2009;7(2):157–167. - PMC - PubMed
    1. Davis LE, Mori M, Keller C. Personalized cancer care: opportunities and challenges in pediatric neuro-oncology. Pediatr. Blood Cancer. 2012;59(1):1–2. - PubMed

LinkOut - more resources